Showing results (431-440 of 662) with videos related to

Sort By:
Pageof 67
Vaccine|October 9, 2013
Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primatesAlida Ault, Sharon M Tennant, J Patrick Gorres, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavirBrian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Lancet (London, England)|August 19, 2014
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trialLee-Jah Chang, Kimberly A Dowd, Floreliz H Mendoza, et al.
Frontiers in Immunology|April 10, 2026
Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposuresAndrew Fiore-Gartland, Koshlan Mayer-Blackwell, James Stray, et al.
Cell Reports|January 30, 2026
Vaccine elicitation of HIV-1 neutralizing antibodies against both V2 apex and fusion peptide in rhesus macaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus MacaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
The Journal of Infectious Diseases|November 17, 2006
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vectorAndrew T Catanzaro, Richard A Koup, Mario Roederer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2022
Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir TreatmentBrian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
The Journal of Clinical Investigation|June 19, 2018
HIV-1 latent reservoir size and diversity are stable following brief treatment interruptionD Brenda Salantes, Yu Zheng, Felicity Mampe, et al.
Medcomm|September 15, 2025
Plasmacytoid and CD141+ Myeloid Dendritic Cells Cooperation with CD8+ T Cells in Lymph Nodes is Associated with HIV ControlJoana Vitallé, Sara Bachiller, Beatriz Dominguez-Molina, et al.
Pageof 67